Litcius/Paper detail

Nanomedicines functionalized with anti-EGFR ligands for active targeting in cancer therapy: Biological strategy, design and quality control

Phuoc-Vinh Nguyen, Émilie Allard-Vannier, Igor Chourpa, Katel Hervé-Aubert

2021International Journal of Pharmaceutics53 citationsDOIOpen Access PDF

Topics & Concepts

NanocarriersEpidermal growth factor receptorNanomedicineTherapeutic indexDrug deliveryIn vivoCancer researchTargeted therapyTargeted drug deliveryImmunotherapyEpidermal growth factorConjugatePharmacologyDrugCancerChemistryMedicineNanotechnologyImmune systemMaterials scienceReceptorBiologyImmunologyNanoparticleBiochemistryMathematicsInternal medicineBiotechnologyMathematical analysisMonoclonal and Polyclonal Antibodies ResearchNanoparticle-Based Drug DeliveryHER2/EGFR in Cancer Research
Nanomedicines functionalized with anti-EGFR ligands for active targeting in cancer therapy: Biological strategy, design and quality control | Litcius